Pricing Log in Create free account

Anika Therapeutics Inc. (ANIK) vs BioAge Labs, Inc. (BIOA)

Anika Therapeutics Inc. and BioAge Labs, Inc. are both Drug Manufacturers Specialty & Generic companies. Anika Therapeutics Inc. is the larger, with a market value of $276.9M against $245.6M — 1.1× the size. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −912.3%) and the higher return on invested capital (−3.24% vs −118.3%). Across the 16 metrics below, Anika Therapeutics Inc. leads on 10 and BioAge Labs, Inc. on 6.

Valuation

Metric ANIK BIOA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 2.21 20.87 2.11
P/B 1.94 0.58 1.78
Price to free cash flow 473.90 n/m 16.14
EV/EBITDA 493.99 0.95 12.58
EV/Sales 2.10 (9.70) 2.73
Earnings yield (1.30%) (49.38%) (4.38%)
Free cash flow yield 0.21% (112.36%) 0.00%

Profitability

Metric ANIK BIOA Drug Manufacturers Specialty & Generic median
Gross margin 62.16% 100.00% 53.94%
Operating margin (4.24%) (1,026.28%) 0.00%
Net margin (3.14%) (912.25%) 0.00%
Free cash flow margin 0.47% (2,345.11%) 0.00%
Return on equity (2.66%) (28.21%) (0.40%)
Return on assets (2.04%) (26.27%) (3.32%)
Return on invested capital (3.24%) (118.25%) 0.00%

Growth

Metric ANIK BIOA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 5.33% — 10.01%
EPS growth (last fiscal year) 80.16% 66.21% 49.06%
Revenue growth, 5-year CAGR (2.86%) — 6.74%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ANIK BIOA Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 4.48 17.19 2.31
Net debt to EBITDA 10.80 3.01 0.97

Dividend

Metric ANIK BIOA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric ANIK BIOA Drug Manufacturers Specialty & Generic median
Market cap 276.90m 245.55m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack